Early Changes in B and Plasma Cell Subsets and Traditional Serological Markers as Predictors of SRI-4 Response to Therapy in Systemic Lupus Erythematosus

OBJECTIVE: With the premise of the hypothesis that early biological responses to therapy for active systemic lupus erythematosus (SLE) portend later clinical improvements, we studied changes in B cell subsets and traditional serological markers in relation to clinical response to standard therapy (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Parodis, Ioannis, Gomez, Alvaro, Lindblom, Julius, Chow, Jun Weng, Doria, Andrea, Gatto, Mariele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096349/
https://www.ncbi.nlm.nih.gov/pubmed/35572992
http://dx.doi.org/10.3389/fmed.2022.852162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096349/
https://www.ncbi.nlm.nih.gov/pubmed/35572992
http://dx.doi.org/10.3389/fmed.2022.852162

Ejemplares similares